Literature DB >> 18167196

Guideline on prevention and treatment of chronic hepatitis B in China (2005).

.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 18167196

Source DB:  PubMed          Journal:  Chin Med J (Engl)        ISSN： 0366-6999            Impact factor:   2.628


× No keyword cloud information.
  49 in total

1.  De novo combination therapy with lamivudine and adefovir dipivoxil in chronic hepatitis B patients.

Authors:  Xiao-Hong Fan; Jian-Zhang Geng; Li-Fen Wang; Ying-Ying Zheng; Hai-Ying Lu; Jing Li; Xiao-Yuan Xu
Journal:  World J Gastroenterol       Date:  2011-11-21       Impact factor: 5.742

2.  Temporal acquisition of sequential mutations in the enhancer II and basal core promoter of HBV in individuals at high risk for hepatocellular carcinoma.

Authors:  Xin Bai; Yu Zhu; Yan Jin; Xia Guo; Gengsun Qian; Taoyang Chen; Jing Zhang; Jinbing Wang; John D Groopman; Jianren Gu; Hong Tu
Journal:  Carcinogenesis       Date:  2010-09-28       Impact factor: 4.944

3.  Correlation between polymorphisms of the E-selectin gene, hepatitis B virus DNA copies, pre-S1 antigen and clinical outcomes during chronic hepatitis B.

Authors:  Weijuan Cai; Liang Yin; Shaoliang Wang; Yu Wei; Wenjiang Cao; Jiang Cheng
Journal:  Int J Clin Exp Med       Date:  2015-02-15

4.  Changes of fecal Bifidobacterium species in adult patients with hepatitis B virus-induced chronic liver disease.

Authors:  Min Xu; Baohong Wang; Yiqi Fu; Yanfei Chen; Fengling Yang; Haifeng Lu; Yunbo Chen; Jiali Xu; Lanjuan Li
Journal:  Microb Ecol       Date:  2011-08-04       Impact factor: 4.552

5.  A comparison of lamivudine vs entecavir for prophylaxis of hepatitis B virus reactivation in allogeneic hematopoietic stem cell transplantation recipients: a single-institutional experience.

Authors:  J Shang; H Wang; J Sun; Z Fan; F Huang; Y Zhang; Q Jiang; M Dai; N Xu; R Lin; Q Liu
Journal:  Bone Marrow Transplant       Date:  2016-01-11       Impact factor: 5.483

6.  Alteration of interferon-α/β receptors in chronic hepatitis B patients.

Authors:  Fanli Meng; Jiefei Wang; Jian Ge; Xiaopeng Fan; Bing Wang; Liyan Han; Tatiana Kisseleva; YongHan Paik; David A Brenner; Kai Wang
Journal:  J Clin Immunol       Date:  2011-03-29       Impact factor: 8.317

7.  Prognostic value of M30/M65 for outcome of hepatitis B virus-related acute-on-chronic liver failure.

Authors:  Su-Jun Zheng; Shuang Liu; Mei Liu; Malcolm A McCrae; Jun-Feng Li; Yuan-Ping Han; Chun-Hui Xu; Feng Ren; Yu Chen; Zhong-Ping Duan
Journal:  World J Gastroenterol       Date:  2014-03-07       Impact factor: 5.742

8.  Prevalent HBV point mutations and mutation combinations at BCP/preC region and their association with liver disease progression.

Authors:  Dake Zhang; Sufang Ma; Xin Zhang; Hanqing Zhao; Huiguo Ding; Changqing Zeng
Journal:  BMC Infect Dis       Date:  2010-09-16       Impact factor: 3.090

9.  Effects of amino acid substitutions in hepatitis B virus surface protein on virion secretion, antigenicity, HBsAg and viral DNA.

Authors:  Kuan-Hui Xiang; Eleftherios Michailidis; Hai Ding; Ya-Qin Peng; Ming-Ze Su; Yao Li; Xue-En Liu; Viet Loan Dao Thi; Xian-Fang Wu; William M Schneider; Charles M Rice; Hui Zhuang; Tong Li
Journal:  J Hepatol       Date:  2016-09-17       Impact factor: 25.083

10.  Prevalence and influences of hepatitis B virus infection on inflammatory bowel disease: a retrospective study in southern China.

Authors:  Yao He; Pingping Xu; Yujun Chen; Rongping Yang; Baili Chen; Zhirong Zeng; Minhu Chen
Journal:  Int J Clin Exp Med       Date:  2015-05-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.